Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Albumin 5%, Hydroxyethyl Starch 130/0.4 (6%) and Ringer Lactate for Volume Replacement During Cardiac Surgery
2005-005040-85Phase 4Completed
- Sponsor
- Medica
- Start
- Feb 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypovolemia and Cardiovascular collapse comparing Albumin 5%, Hydroxyethyl starch 130/0.4 (6%) and Ringer lactate (3 arms). Primary endpoint: Cumulative mediastinal blood loss at 24 hours after cardiopulmonary bypass. Started Feb 2006; status: completed.
02
Drugs
albumin (human)hetastarchlactated ringer's solution
03
Conditions
hypovolemiaCardiovascular collapse
Beyond the preview
Go deeper on 2005-005040-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005040-85.